Bionano Genomics (BNGO) Assets (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Assets data on file, last reported at $64.8 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 17.36% year-over-year to $64.8 million; the trailing twelve-month figure through Mar 2026 stood at $64.8 million (down 17.36% YoY), and the FY2025 full-year result was $73.6 million, down 4.03% from the prior year.
• Assets slipped to $64.8 million in Q1 2026, from $73.6 million in the prior quarter.
• In the past five years, Assets ranged from a high of $348.2 million in Q1 2022 to a low of $64.8 million in Q1 2026.
• A 5-year average of $181.4 million and a median of $158.0 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets slumped 64.24% in 2024 and decreased 4.03% in 2025, its largest moves.
• Tracing BNGO's Assets over 5 years: stood at $307.5 million in 2022, then tumbled by 30.28% to $214.4 million in 2023, then tumbled by 64.24% to $76.7 million in 2024, then fell by 4.03% to $73.6 million in 2025, then declined by 11.93% to $64.8 million in 2026.
• Business Quant data shows BNGO's Assets at $64.8 million in Q1 2026, $73.6 million in Q4 2025, and $79.1 million in Q3 2025.